Sign in

    Dave Hammond

    Research Analyst at Private Investor

    Dave Hammond is an Analyst specializing in investment analysis at Private Investor, focusing on evaluating healthcare and life sciences companies. He tracks a select group of firms within the sector, delivering research-driven insights to support investment decisions, though specific company names and detailed performance metrics are not publicly disclosed. Hammond began his career as an analyst and has maintained this role at Private Investor, leveraging strong analytical skills alongside his experience with investment research teams. He holds professional designations relevant to investment roles, but there is no publicly available record of FINRA registration or securities licenses tied directly to his name.

    Dave Hammond's questions to Envirotech Vehicles (EVTV) leadership

    Dave Hammond's questions to Envirotech Vehicles (EVTV) leadership • Q2 2022

    Question

    Dave Hammond, a private investor, asked for clarification on the 100-unit order structure with DaVinci Innovations and how related sales would be disclosed. He also inquired about the status of a potential financing following the NASDAQ uplist and sought details on the new 84-passenger school bus opportunity.

    Answer

    CEO Phillip Oldridge explained that the DaVinci dealer relationship is required by Arkansas state law, which currently prohibits direct-to-customer sales by manufacturers, though they are working to change this. He confirmed the 100-unit order is firm with end customers. Regarding financing, he stated a deal is likely in Q3, explaining they proceeded with the uplist without a concurrent financing due to unfavorable market conditions at the time. He clarified the company is developing an 84-passenger school bus, with five units expected by year-end, and also mentioned progress on a prisoner transport van and right-hand drive vehicles.

    Ask Fintool Equity Research AI